Key result
An evaluation scheme is proposed to help physicians differentiate life-threatening causes of syncope from benign neurally mediated syncope in children and adolescents.
Provides a structured evaluation scheme for pediatric syncope to identify life-threatening causes and guide appropriate management.
May aid differentiation of pediatric syncope; leaves open prospective validation before clinical adoption.
Syncope in children is most often neurally mediated and usually has a natural history of spontaneous resolution or improvement. Syncope is defined as the temporary loss of consciousness resulting from a reversible disturbance of cerebral function. It is characterized by a loss of consciousness due to a lack of cerebral blood flow, rapid or sudden onset, falling of the patient, if not supported, and transiency of the attack. In children, it is most often benign, but may sometimes herald a more serious, potentially life-threatening cause. The main purpose of the present paper is to propose an evaluation scheme that will allow the physician involved in the care of children to differentiate the life-threatening causes of syncope with potential for injury or sudden death from the common, more benign neurally mediated syncope. Secondarily, the present article facilitates the identification of the patient with neurally mediated syncope who may benefit from medical therapy and distinguishes syncope from the more frequent noncardiac 'spells' of childhood.
No takes yet. Share an insight, caveat, or question.
Jean‐Marc Côté (2001) conducted a review in Syncope. Evaluation scheme was evaluated. An evaluation scheme is proposed to help physicians differentiate life-threatening causes of syncope from benign neurally mediated syncope in children and adolescents.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: